About This Episode
Are Wegovy and Ozempic really “miracle” drugs, or is there more to the story?
In this episode, metabolic health expert Dr. Beverly Yates and UCSF weight management specialist Dr. Gina Moreno-John, MD, MPH, dive deep into the science of modern weight loss medications. Learn how injectable peptide therapies (like Semaglutide and Tirzepatide) target metabolic hormones to lower blood sugar, fix insulin resistance, and reduce appetite.
We also tackle the critical side effects you need to know about—including the truth behind “Ozempic Face” and why preserving muscle mass through resistance training is vital. If you want an honest, medical perspective on the future of weight management and Type 2 diabetes reversal, hit play now!
Guest Bio: Dr. Gina Moreno-John, MD, MPH
Dr. Gina Moreno-John is a distinguished clinician and faculty member at UCSF specializing in primary care and weight management. Driven by a deep commitment to social justice and health equity, she serves as the director of DTI in the Division of General Internal Medicine. Dr. Moreno-John has pioneered innovative food bank programs within clinical settings to address the root causes of metabolic disease and food insecurity in vulnerable communities.
Connect with Dr. Gina Moreno-John
Professional Profile: UCSF Faculty Directory
Clinic: UCSF Weight Management Program
Never Miss an Episode
New conversations with Dr. Yates and leading experts on blood sugar, insulin resistance and reversing type 2 diabetes naturally.
